Package 16571-758-50

{"route": ["ORAL"], "spl_id": "9ed1dbe4-49df-4d94-9e8b-3cdc081a3dd0", "openfda": {"nui": ["N0000175428", "N0000175448"], "unii": ["41X3PWK4O2"], "rxcui": ["311919", "314142"], "spl_set_id": ["b41f4180-96a7-411d-b827-5021e534f556"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (16571-758-01)", "package_ndc": "16571-758-01", "marketing_start_date": "20201216"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (16571-758-09)", "package_ndc": "16571-758-09", "marketing_start_date": "20201216"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (16571-758-50)", "package_ndc": "16571-758-50", "marketing_start_date": "20201216"}], "brand_name": "NATEGLINIDE", "product_id": "16571-758_9ed1dbe4-49df-4d94-9e8b-3cdc081a3dd0", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "16571-758", "generic_name": "NATEGLINIDE", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NATEGLINIDE", "active_ingredients": [{"name": "NATEGLINIDE", "strength": "60 mg/1"}], "application_number": "ANDA205544", "marketing_category": "ANDA", "marketing_start_date": "20201216", "listing_expiration_date": "20261231"}